Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1

The promise of adaptive cancer immunotherapy in treating highly malignant tumors such as glioblastoma multiforme (GBM) can only be realized through expanding its benefits to more patients. Alleviating various modes of immune suppression has so far failed to achieve such expansion, but exploiting end...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordner, Ryan, Jhun, Michelle, Panwar, Akanksha, Wang, HongQiang, Gull, Nicole, Murali, Ramachandran, McAbee, Joseph H., Mardiros, Armen, Sanchez-Takei, Akane, Mazer, Mia W., Fan, Xuemo, Jouanneau, Emmanuel, Yu, John S., Black, Keith L., Wheeler, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275753/
https://www.ncbi.nlm.nih.gov/pubmed/37161052
http://dx.doi.org/10.1038/s41388-023-02713-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275753/
https://www.ncbi.nlm.nih.gov/pubmed/37161052
http://dx.doi.org/10.1038/s41388-023-02713-7

Ejemplares similares